Ginsenoside Re and Rd enhance the expression of cholinergic markers and neuronal differentiation in neuro-2a cells

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 5, 2014, Pages 826-833

  Kim, Min Soo ^a   Yu, Jung Min ^b   Kim, Hee Jung ^b   Kim, Hae Bok ^b   Kim, Seung Tae ^b   Jang, Su Kil ^b   Choi, Young Wook ^a   Lee, Do Ik ^a   Joo, Seong Soo ^b  

^a Chung Ang University   (South Korea)

^b Gangneung Wonju National University   (South Korea)

Author keywords

Acetylcholine; Alzheimer's disease; Choline acetyltransferase; Ginsenoside; Vesicular acetylcholine transporter

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; GINSENOSIDE RB 1; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 3; K 252A; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN RECEPTOR P75; PROTEIN KINASE B; PROTEIN P21; PROTEIN TYROSINE KINASE A; VESICULAR ACETYLCHOLINE TRANSPORTER; BIOLOGICAL MARKER; GINSENOSIDE; MICROTUBULE ASSOCIATED PROTEIN; NERVE GROWTH FACTOR RECEPTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL STRAIN; CHAT GENE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME INHIBITION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAP 2 GENE; MOUSE; NERVE CELL DIFFERENTIATION; NEURO 2A CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; P21 GENE; P75 GENE; PROTEIN EXPRESSION; TRKA GENE; UPREGULATION; VACHT GENE; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; NERVE CELL;

ACETYLCHOLINE; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION REGULATION; GINSENOSIDES; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RHO GTP-BINDING PROTEINS; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 84899834835     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00011     Document Type: Article

References (40)

1. Esposito E, Cuzzocrea S. New therapeutic strategy for Parkinson's and Alzheimer's disease. Curr. Med. Chem., 17, 2764-2774 (2010).
2. Giacobini E. Cholinergic function and Alzheimer's disease. Int. J. Geriatr. Psychiatry, 18 (Suppl. 1), S1-S5 (2003).
3. Oda Y. Choline acetyltransferase: The structure, distribution and pathologic changes in the central nervous system. Pathol. Int., 49, 921-937 (1999).
4. Roghani A, Carroll PT. Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT). Brain Res. Mol. Brain Res., 100, 21-30 (2002).
5. Chen KH, Reese EA, Kim H-W, Rapoport SI, Rao JS. Disturbed neurotransmitter transporter expression in Alzheimer disease brain. J. Alzheimers Dis., 26, 755-766 (2011).
6. Berse B, Blusztajn JK. Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J. Biol. Chem., 270, 22101-22104 (1995).
7. Yamamuro Y, Aizawa S. Asymmetric regulation by estrogen at the cholinergic gene locus in differentiated NG108-15 neuronal cells. Life Sci., 86, 839-843 (2010).
8. Park D, Lee HJ, Joo SS, Bae DK, Yang G, Yang YH, Lim I, Matsuo A, Tooyama I, Kim YB, Kim SU. Human neural stem cells overexpressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction. Exp. Neurol., 234, 521-526 (2012).
9. Yamada M, Chiba T, Sasabe J, Terashita K, Aiso S, Matsuoka M. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease. Neuropsychopharmacology, 33, 2020-2032 (2008).
10. Counts SE, He B, Che S, Ginsberg SD, Mufson EJ. Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease. Neurodegener. Dis., 5, 228-231 (2008).
11. Fukasawa H, Nakagomi M, Yamagata N, Katsuki H, Kawahara K, Kitaoka K, Miki T, Shudo K. Tamibarotene: A candidate retinoid drug for Alzheimer's disease. Biol. Pharm. Bull., 35, 1206-1212 (2012).
12. Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev., 13, 381-404 (2007).
13. Chang Y, Huang WJ, Tien LT, Wang SJ. Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes). Eur. J. Pharmacol., 578, 28-36 (2008).
14. Benishin CG, Lee R, Wang LC, Liu HJ. Effects of ginsenoside Rb1 on central cholinergic metabolism. Pharmacology, 42, 223-229 (1991).
15. Okuda T, Konishi A, Misawa H, Haga T. Substrate-induced internalization of the high-affinity choline transporter. J. Neurosci., 31, 14989-14997 (2011).
16. Williams B, Granholm AC, Sambamurti K. Age-dependent loss of NGF signaling in the rat basal forebrain is due to disrupted MAPK activation. Neurosci. Lett., 413, 110-114 (2007).
17. Madziar B, Shah S, Brock M, Burke R, Lopez-Coviella I, Nickel AC, Cakal EB, Blusztajn JK, Berse B. Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt/PKB signaling pathway. J. Neurochem., 107, 1284-1293 (2008).
18. MacDonald SC, Fleetwood IG, Hochman S, Dodd JG, Cheng GK, Jordan LM, Brownstone RM. Functional motor neurons differentiating from mouse multipotent spinal cord precursor cells in culture and after transplantation into transected sciatic nerve. J. Neurosurg., 98, 1094-1103 (2003).
19. Schnitzler AC, Lopez-Coviella I, Blusztajn JK. Differential modulation of nerve growth factor receptor (p75) and cholinergic gene expression in purified p75-expressing and non-expressing basal forebrain neurons by BMP9. Brain Res., 1246, 19-28 (2008).
20. Akpan N, Caradonna K, Chuenkova MV, PereiraPerrin M. Chagas' disease parasite-derived neurotrophic factor activates cholinergic gene expression in neuronal PC12 cells. Brain Res., 1217, 195-202 (2008).
21. Woolf NJ, Milov AM, Schweitzer ES, Roghani A. Elevation of nerve growth factor and antisense knockdown of TrkA receptor during contextual memory consolidation. J. Neurosci., 21, 1047-1055 (2001).
22. Terry AV Jr, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther., 306, 821-827 (2003).
23. Pfeil U, Vollerthun R, Kummer W, Lips KS. Expression of the cholinergic gene locus in the rat placenta. Histochem. Cell Biol., 122, 121-130 (2004).
24. Izant JG, McIntosh J. Microtubule-associated proteins: a monoclonal antibody to MAP-2 binds to differentiated neurons. Proc. Natl. Acad. Sci. U.S.A., 77, 4741-4745 (1980).
25. Wong TP, Debeir T, Duff K, Cuello AC. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci., 19, 2706-2716 (1999).
26. Tian X, Sun X, Suszkiw JB. Developmental age-dependent upregulation of choline acetyltransferase and vesicular acetylcholine transporter mRNA expression in neonatal rat septum by nerve growth factor. Neurosci. Lett., 209, 134-136 (1996).
27. Niewiadomska G, Mietelska-Porowska A, Mazurkiewicz M. The cholinergic system, nerve growth factor and the cytoskeleton. Behav. Brain Res., 221, 515-526 (2011).
28. Wu PY, Lin YC, Chang CL, Lu HT, Chin CH, Hsu TT, Chu D, Sun SH. Functional decreases in P2X7 receptors are associated with retinoic acid-induced neuronal differentiation of Neuro-2a neuroblastoma cells. Cell. Signal., 21, 881-891 (2009).
29. De Gois S, Houhou L, Oda Y, Corbex M, Pajak F, Thévenot E, Vodjdani G, Mallet J, Berrard S. Is RE1/NRSE a common cis-regulatory sequence for ChAT and VAChT genes? J. Biol. Chem., 275, 36683-36690 (2000).
30. Yamaguchi Y, Tabata K, Asami S, Miyake M, Suzuki T. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma. Biol. Pharm. Bull., 30, 638-643 (2007).
31. Kippin TE, Martens DJ, van der Kooy D. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev., 19, 756-767 (2005).
32. Qiu MS, Green SH. NGF and EGF rapidly activate p21ras in PC12 cells by distinct, convergent pathways involving tyrosine phosphorylation. Neuron, 7, 937-946 (1991).
33. Bruno JG, Carrillo MP, Phillips T, King B. Development of DNA aptamers for cytochemical detection of acetylcholine. In Vitro Cell. Dev. Biol. Anim., 44, 63-72 (2008).
34. Pardridge WM. CNS drug design based on principles of blood-brain barrier transport. J. Neurochem., 70, 1781-1792 (1998).
35. Odani T, Tanizawa H, Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponin. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chem. Pharm. Bull., 31, 292-298 (1983).
36. Tachikawa E, Kudo K. Proof of the mysterious efficacy of ginseng: basic and clinical trials: suppression of adrenal medullary function in vitro by ginseng. J. Pharmacol. Sci., 95, 140-144 (2004).
37. Wu J, Jeong HK, Bulin SE, Kwon SW, Park JH, Bezprozvanny I. Ginsenosides protect striatal neurons in a cellular model of Huntington's disease. J. Neurosci. Res., 87, 1904-1912 (2009).
38. Musende AG, Eberding A, Wood CA, Adomat H, Fazli L, Hurtado-Coll A, Jia W, Bally MB, Tomlinson Guns ES. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer. Anticancer Drugs, 23, 543-552 (2012).
39. Hao K, Gong P, Sun SQ, Hao HP, Wang GJ, Dai Y, Liang Y, Xie L, Li FY. Beneficial estrogen-like effects of ginsenoside Rb1, an active component of Panax ginseng, on neural 5-HT disposition and behavioral tasks in ovariectomized mice. Eur. J. Pharmacol., 659, 15-25 (2011).
40. Bora SH, Liu Z, Kecojevic A, Merchenthaler I, Koliatsos VE. Direct, complex effects of estrogens on basal forebrain cholinergic neurons. Exp. Neurol., 194, 506-522 (2005).